Former British Columbia Premier Christy Clark said Canopy Growth (NYSE:CGC,TSX:WEED) is the “best positioned of all the companies” in the highly regulated cannabis sector.

Constellation Brands (NYSE:STZ), one of Canopy Growth’s biggest partners, confirmed Clark’s appointment to its board of directors in September, alongside Jose Manuel Madero, citing Clark’s “extensive knowledge” of Canada’s regulatory and political environment as benefits.

Clark sat as the provincial premier from 2011 to 2017 after working as both the minister of education and minister of children and family development in British Columbia.

In an interview with BNN Bloomberg on Friday (October 4), the former politician spoke about her excitement at joining the ranks at Constellation, a company she said is skilled at delivering on products in highly regulated industries.

Clark noted that the fledgling regulatory environment of the marijuana market won’t be well served by having a lot of smaller companies selling cannabis, but said Canopy Growth and Constellation have the capability to make the safe creation and distribution of cannabis products possible.

“There aren’t really any other companies in the cannabis space at the moment that have this level of capacity,” she said.

The former British Columbia premier isn’t the only player in the cannabis space with a political past. Former Canadian Prime Minister Brian Mulroney and former Speaker of the House John Boehner have both backed cannabis company Acreage Holdings (CSE:ACRG.U,OTCQX:ACRGF), another firm with a Canopy Growth deal.

Clark added that there is “huge potential on the (intellectual property) side” when it comes to the nascent industry, and said that further research on the medicinal applications of marijuana will be the biggest driver of growth. It is a space, she said, that Constellation will dominate.

The American beer maker pumped C$5 billion into Canopy last year to assist in branding, intellectual property and retailing for the cannabis company.

Clark’s addition to Constellation’s roster was another big management move for the company after former Canopy CEO Bruce Linton was pushed out of his role as chief executive.

With the investment, a conditional board reconfigurement was set, and that same board, largely composed of Constellation executives, terminated Linton after being unimpressed by some less-than-stellar quarterly results.

Shares of Constellation took a hit last week after it released its results for Q2 2020 on Thursday (October 3). The company reported a loss of US$484.4 million from its stake in Canopy Growth.

Constellation also reported a US$757 million unrealized net gain in reported basis results since its initial C$245 million investment into Canopy in 2017. A US$839 million decrease in the fair value of its investment into Canopy was also recognized during the latest quarter for the alcohol maker.

Shares of Constellation dropped after the earnings report was released last week, falling 8.2 percent from a high of US$208.14 on Wednesday (October 2) to a low of US$191.02 on Thursday.

Constellation closed the trading day on Monday (October 7) at US$188.74.

Canopy Growth shares fared a bit better last week with a bit of fluctuation in New York from a high on Wednesday of US$22.58 to a low of US$21.52 on Thursday, a 4.7 percent decrease in value. Canopy was at US$22.23 at market close on Monday.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Danielle Edwards, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Acreage Holdings is a client of the Investing News Network. This article is not paid-for content.

Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Lobe Sciences Ltd. (CSE: LOBE) (OTC Pink: GTSIF) (“Lobe” or the “Company”) is pleased to announce the appointment of Bart Oates Esq., President of the NFL Alumni Association, to its Advisory Board.

Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).

This press release features multimedia. View the full release here:

Keep reading... Show less